DePuy, Others Urge FDA Not To Lump Together Hip Implants
Representatives from the manufacturers presented safety data to the 18-member panel during the first session of a highly anticipated two-day meeting about the devices. The panel is considering whether to issue new recommendations to physicians and patients about the implants and whether to change their labeling.
Already a subscriber? Click here to login